No, Balthasar is not a biotech company. Think fast! Aragorn, Legolas and Gimli. Athos, Porthos and Aramis. Jaclyn, Farrah and Kate. Kirk, Spock and Bones. Barry, Robin and Maurice. Shadrach, Meshach and Abednego. History and culture bestow trios upon us because threesomes keep us rapt. The Three Magi, liking the Gummune as they do, have […]
Articles
Today we’re taking a quick look at a teaser ad that went around late last week, for Cabot’s Emerging Markets Investor. That’s the letter that used to be called Cabot China & Emerging Markets Report, it’s changed names to reflect the relative lack of popularity of Chinese stock picking these days but is still edited […]
The ad one everyone’s asking about today is from Louis Navellier, it’s a pitch for his Emerging Growth newsletter (currently $995/year) — and this might be the first time we’ve seen the “Tesla of XXX Sector” marketing spiel. Perhaps it’s a changing of the guard, we used to be told we were looking at the […]
Criminy, I definitely couldn’t pick three stocks that I think have the absolute best chance of making you rich over the next six months — but that’s the promise from Louis Navellier in the latest ad for his Emerging Growth newsletter. And naturally, he says we have “only 48 hours!” So I guess I’d better […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
No comments.